NEO1
Neogenin
Also known as: HsT17534, IGDCC2, NEO1_HUMAN, NGN, NTN1R2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92859
- Gene
- NEO1
- Ensembl
- ENSG00000067141
- Chromosome
- 15
- Canonical length
- 1461 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Plasma membrane
OverviewNCBI Gene
This gene encodes a cell surface protein that is a member of the immunoglobulin superfamily. The encoded protein consists of four N-terminal immunoglobulin-like domains, six fibronectin type III domains, a transmembrane domain and a C-terminal internal domain that shares homology with the tumor suppressor candidate gene DCC. This protein may be involved in cell growth and differentiation and in cell-cell adhesion. Defects in this gene are associated with cell proliferation in certain cancers. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
Canonical amino-acid sequenceUniProt
1461 residues, UniProt reviewed canonical sequence.
>Q92859|NEO1
1 MAAERGARRL LSTPSFWLYC LLLLGRRAPG AAAARSGSAP QSPGASIRTF TPFYFLVEPV
61 DTLSVRGSSV ILNCSAYSEP SPKIEWKKDG TFLNLVSDDR RQLLPDGSLF ISNVVHSKHN
121 KPDEGYYQCV ATVESLGTII SRTAKLIVAG LPRFTSQPEP SSVYAGNNAI LNCEVNADLV
181 PFVRWEQNRQ PLLLDDRVIK LPSGMLVISN ATEGDGGLYR CVVESGGPPK YSDEVELKVL
241 PDPEVISDLV FLKQPSPLVR VIGQDVVLPC VASGLPTPTI KWMKNEEALD TESSERLVLL
301 AGGSLEISDV TEDDAGTYFC IADNGNETIE AQAELTVQAQ PEFLKQPTNI YAHESMDIVF
361 ECEVTGKPTP TVKWVKNGDM VIPSDYFKIV KEHNLQVLGL VKSDEGFYQC IAENDVGNAQ
421 AGAQLIILEH APATTGPLPS APRDVVASLV STRFIKLTWR TPASDPHGDN LTYSVFYTKE
481 GIARERVENT SHPGEMQVTI QNLMPATVYI FRVMAQNKHG SGESSAPLRV ETQPEVQLPG
541 PAPNLRAYAA SPTSITVTWE TPVSGNGEIQ NYKLYYMEKG TDKEQDVDVS SHSYTINGLK
601 KYTEYSFRVV AYNKHGPGVS TPDVAVRTLS DVPSAAPQNL SLEVRNSKSI MIHWQPPAPA
661 TQNGQITGYK IRYRKASRKS DVTETLVSGT QLSQLIEGLD RGTEYNFRVA ALTINGTGPA
721 TDWLSAETFE SDLDETRVPE VPSSLHVRPL VTSIVVSWTP PENQNIVVRG YAIGYGIGSP
781 HAQTIKVDYK QRYYTIENLD PSSHYVITLK AFNNVGEGIP LYESAVTRPH TDTSEVDLFV
841 INAPYTPVPD PTPMMPPVGV QASILSHDTI RITWADNSLP KHQKITDSRY YTVRWKTNIP
901 ANTKYKNANA TTLSYLVTGL KPNTLYEFSV MVTKGRRSST WSMTAHGTTF ELVPTSPPKD
961 VTVVSKEGKP KTIIVNWQPP SEANGKITGY IIYYSTDVNA EIHDWVIEPV VGNRLTHQIQ
1021 ELTLDTPYYF KIQARNSKGM GPMSEAVQFR TPKADSSDKM PNDQASGSGG KGSRLPDLGS
1081 DYKPPMSGSN SPHGSPTSPL DSNMLLVIIV SVGVITIVVV VIIAVFCTRR TTSHQKKKRA
1141 ACKSVNGSHK YKGNSKDVKP PDLWIHHERL ELKPIDKSPD PNPIMTDTPI PRNSQDITPV
1201 DNSMDSNIHQ RRNSYRGHES EDSMSTLAGR RGMRPKMMMP FDSQPPQPVI SAHPIHSLDN
1261 PHHHFHSSSL ASPARSHLYH PGSPWPIGTS MSLSDRANST ESVRNTPSTD TMPASSSQTC
1321 CTDHQDPEGA TSSSYLASSQ EEDSGQSLPT AHVRPSHPLK SFAVPAIPPP GPPTYDPALP
1381 STPLLSQQAL NHHIHSVKTA SIGTLGRSRP PMPVVVPSAP EVQETTRMLE DSESSYEPDE
1441 LTKEMAHLEG LMKDLNAITT ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against NEO1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 52 nTPM
Expression across tissuesHPA
Tissue
- rectum: 52 nTPM
- colon: 43 nTPM
- parathyroid gland: 39 nTPM
- skin: 35 nTPM
- seminal vesicle: 34 nTPM
- prostate: 31 nTPM
Single-cell type
- myonuclei: 631 nCPM
- oligodendrocytes: 518 nCPM
- astrocytes: 372 nCPM
- bergmann glia: 369 nCPM
- proximal tubule cells: 250 nCPM
- prostatic glandular cells: 247 nCPM
Immune cell
- MAIT T-cell: 0.7 nTPM
- gdT-cell: 0.4 nTPM
- memory CD8 T-cell: 0.3 nTPM
- neutrophil: 0.3 nTPM
- memory CD4 T-cell: 0.2 nTPM
- NK-cell: 0.2 nTPM
Brain region
- white matter: 123 nTPM
- basal ganglia: 92 nTPM
- cerebellum: 82 nTPM
- midbrain: 82 nTPM
- thalamus: 79 nTPM
- medulla oblongata: 77 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.35
- gnomAD pLI
- 0.24
- gnomAD missense Z
- 1.63
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon guidance
- cell adhesion
- cell-cell adhesion
- intracellular iron ion homeostasis
- multicellular organismal-level iron ion homeostasis
- myoblast fusion
- negative regulation of axon regeneration
- negative regulation of protein secretion
- neuron migration
- positive regulation of BMP signaling pathway
- protein secretion
- regulation of DNA-templated transcription
- trans-synaptic signaling, modulating synaptic transmission
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Fibronectin type III
- Immunoglobulin-like domain
- Neogenin, C-terminal
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Fibronectin type III superfamily
- Immunoglobulin-like domain superfamily
- Fibronectin type III domain
- Neogenin C-terminus
- Immunoglobulin I-set domain
- Immunoglobulin domain
- Immunoglobulin domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NEO1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NEO1 as an antibody target. Whether an autoantibody or antibody against NEO1 could matter depends on whether native NEO1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NEO1 is annotated at the cell surface, where native NEO1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NEO1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...